Scroll Top
Gain Therapeutics Inc.

Bial drops pariceract after Phase IIb failure in GBA-associated Parkinson’s

European Biotechnology

June 09, 2026

Bial drops pariceract after Phase IIb failure in GBA-associated Parkinson’s

 

Latest Articles

Clear Filters
June 10, 2026
Four emerging technologies reshaping neurology in 2026
https://www.labiotech.eu/in-depth/neurology-technology/
Read More
June 9, 2026
Bial drops pariceract after Phase IIb failure in GBA-associated Parkinson’s
https://european-biotechnology.com/latest-news/bial-drops-pariceract-after-phase-iib-failure-in-gba-associated-parkinsons/
Read More
May 27, 2026
Gain Therapeutics expands ‘compelling’ evidence base for Parkinson’s candidate
https://finance.yahoo.com/sectors/healthcare/articles/gain-therapeutics-expands-compelling-evidence-043446986.html
Read More